JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastomaToshihiko Wakabayashi, Soichiro Shibui, Ryo Nishikawa et al.|Journal of Neuro-Oncology|2018Cited by 65
Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305)Soichiro Shibui, Kazuhiro Nomura, Yoshitaka Narita et al.|Cancer Chemotherapy and Pharmacology|2012Cited by 31
Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide aloneAtsushi Natsume, Toshihiko Wakabayashi, Kosuke Aoki et al.|Journal of Neuro-Oncology|2020Cited by 11